Your session is about to expire
← Back to Search
HIFT 1x/week for Metabolic Syndrome
Study Summary
This trial will study the effects of different intensities and volumes of functional training on various biomarkers related to heart health and diabetes. Additionally, it will look at participants' enjoyment of the exercise and their intent to continue the program.
- Metabolic Syndrome
- Insulin Resistance
- Atherogenic Dyslipidemia
- Endothelial Dysfunction
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
What specific goals has this clinical trial set out to achieve?
"This clinical trial will assess its primary objective, a change in total triglyceride content of all lipoprotein classes (TG) over baseline and 48hrs after 12 weeks of training. Secondary outcomes include changes from baseline to post-training body lean mass percentage (LM%) measured via dual X-ray absorptiometry (DEXA), maximal oxygen consumption (VO2max) assessed through a graded exercise test on a power treadmill, as well as self-perceived fitness recorded with the International Fitness Scale at the conclusion of the 12 weeks."
Is it possible for me to partake in this medical study?
"For this medical trial to be successful, 60 qualified individuals are needed. The key qualifications include being between 35-65 years old and having metabolic syndrome; furthermore, participants must also demonstrate a history of physical inactivity for the past 3 months."
How many individuals are contributing to this medical experiment?
"Affirmative. Evidenced on clinicaltrials.gov, this medical research study is currently recruiting volunteers - with the initial posting dating to September 1st 2022 and last update occurring July 12th 2022. 60 participants are required across a single site."
Does this experiment accept volunteers aged 85 and older?
"This particular study only allows patients aged between 35 to 65 years old. Conversely, there are 413 trials that accept minors and 1208 studies open for seniors."
Does this trial still have open spots for participation?
"The information posted to clinicaltrials.gov demonstrates that this medical trial is presently enrolling patients; the study was first listed on September 1st 2022 and its details most recently modified on July 12th 2022."
Who else is applying?
What state do they live in?
How old are they?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger